Ketazolam
Product Description
F.I.S. Fabbrica Italiana Sintetici SpA
-
IT
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
F.I.S. Fabbrica Italiana Sintetici SpA
-
IT
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
More Products from F.I.S. Fabbrica Italiana Sintetici SpA (26)
-
Product Estazolam
FIS produces a wide range of API's which includes Estazolam. It is commercially available. Contact us for more information. -
Product Flunitrazepam
FIS produces a wide range of API's which includes Flunitrazepam. It is commercially available. Contact us for more information. -
Product Flurazepam
FIS produces a wide range of API's which includes Flurazepam. It is commercially available. Contact us for more information. -
Product Furosemide
FIS produces a wide range of API's which includes Furosemide. It is commercially available. Contact us for more information. -
Product Gabapentin
FIS produces a wide range of API's which includes Gabapentin. It is commercially available. Contact us for more information. -
Product Indomethacin
FIS produces a wide range of API's which includes Indomethacin. It is commercially available. Contact us for more information. -
Product Midazolam
FIS produces a wide range of API's which includes Midazolam. It is commercially available. Contact us for more information. -
Product Nitrazepam
FIS produces a wide range of API's which includes Nitrazepam. It is commercially available. Contact us for more information. -
Product Olopatadine Hydrochloride
FIS produces a wide range of API's which includes Olopatadine Hydrochloride. It is commercially available. Contact us for more information. -
Product Oxazepam
FIS produces a wide range of API's which includes Oxazepam. It is commercially available. Contact us for more information. -
Product Pentazocine
FIS produces a wide range of API's which includes Pentazocine. It is commercially available. Contact us for more information. -
Product Prazepam
FIS produces a wide range of API's which includes Prazepam. It is commercially available. Contact us for more information.
F.I.S. Fabbrica Italiana Sintetici SpA resources (1)
-
News Revenues up 20% in 2022
The growth trend remains in the first quarter of 2023: revenues of €153 million, up 31% compared to the first quarter of 2022
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance